Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1

Status

Active not recruiting 6Completed 5Recruiting 4Unknown 2Terminated 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 4Genitourinary 2Gastrointestinal 2CNS 2Sarcoma 1Other solid neoplasm 1Lymphoid 1Endocrine 1

Conditions

Prostatic Neoplasms 2Neoplasms 1

Interventions

Docetaxel 69pembrolizumab 48Prednisone 43Nivolumab 40enzalutamide 38Gemcitabine 37Sunitinib 36Cyclophosphamide 29Radiotherapy 26Magnetic Resonance Spectroscopy 26Leuprolide 25Abiraterone Acetate 25Sorafenib 23Everolimus 23Cisplatin 23bicalutamide 19atezolizumab 18Carboplatin 18Bevacizumab 18avelumab 17Radiosurgery 17Goserelin 17Interleukin-2 16abiraterone 15fludarabine 14Doxorubicin 14olaparib 13durvalumab 13cabozantinib 13acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Proton Therapy × Genitourinary × Clear all
NCT01045226 2023-02-01

Proton Radiation Therapy in Treating Patients With Prostate Cancer

Abramson Cancer Center at Penn Medicine

Phase NA Terminated
300 enrolled
Genitourinary

Prostatic Neoplasms

NCT01603420 2016-03-14

External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer

Proton Collaborative Group

Phase 2/3 Terminated
2 enrolled 8 charts
Genitourinary

Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡